Why the study?
With improved prognosis in cancer patients, the incidence of venous thromboembolism is increasing, prompting investigation into the characteristics and prognosis of cancer-associated thrombosis.
In cancer patients with VTE, asymptomatic presentations are common, and elevated D-dimer (≥6 µg/mL) is a significant predictor of poor overall survival.
High D-dimer signals worse survival in cancer-associated VTE; leaves open its role for risk stratification in prospective studies.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Tsuyuki et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: